☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
AltruBio
AltruBio Receives the US FDA’s IND Clearance to Initiate a P-II Clinical Trial of ALTB-268 for Ulcerative Colitis
September 27, 2023
AltruBio Reports the Completion of Patient Enrollment in P-I Clinical Study of Neihulizumab (ALTB-168) for Steroid-Refractory Acut...
May 13, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.